Építés alatt – nem éles oldal
Belépés

What researchers published on Myasthenia gravis

5934 papers, newest first.

Showing 40 of 5934

  • EsetismertetésZilucoplan as Plan B-Complement Inhibition as Rescue Therapy for Refractory Myasthenic Crisis in Thymomatous Myasthenia Gravis.Muscle & nerve
  • Cross-Sectional Serological Profile Anti-AChR by ELISA of a Brazilian Cohort of Patients With Suspected Myasthenia Gravis.Journal of immunology research
  • EsetismertetésAssociation Between Myasthenia Gravis and Sarcoidosis: A Case Report.Cureus
  • HLA profiles in immune checkpoint inhibitor-associated neuromuscular adverse events.Frontiers in immunology
  • Correction: Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.Frontiers in immunology
  • Szisztematikus áttekintésLong‑term disease control in generalized myasthenia gravis: a systematic literature review.BMC neurology
  • Clinical and treatment profiles of myasthenic crisis patients in a tertiary hospital in the Philippines: a single-center retrospective study.BMC neurology
  • Response to the comment on "A potential biomarker for the efficacy of complement inhibitors in myasthenia gravis".Journal of the neurological sciences
  • EsetismertetésWhen Fluctuating Ptosis and Diplopia Are Not Myasthenia Gravis: A Case of Eosinophilic Orbital Myositis Treated With IL-5 Inhibition.Muscle & nerve
  • Transient Worsening of Myasthenia Gravis Temporally Associated With Meningococcal Vaccination During Preparation for Complement C5 Inhibitor Therapy.Journal of clinical neurology (Seoul, Korea)
  • Assessing the Degree of Patient-Physician Agreement on Perceived Disease Burden in Generalised Myasthenia Gravis: A European Study.Neurology and therapy
  • Monocyte-to-HDL Cholesterol Ratio and Complete Blood Count-Derived Inflammatory Markers in Myasthenia Gravis: A Cross-Sectional Case-Control Study.Journal of clinical medicine
  • Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis.Muscle & nerve
  • ÁttekintésFrom seropositivity to pathogenicity: causal evidence for autoantibodies in myasthenia gravis.Frontiers in immunology
  • Time for functional complement biomarkers in generalized Myasthenia Gravis.Journal of the neurological sciences
  • EsetismertetésCase Report: Fulminant sintilimab-associated myocarditis complicated by complete atrioventricular block and suspected myositis-myasthenia gravis overlap syndrome.Frontiers in cardiovascular medicine
  • Esetismertetés[Nasopharyngeal carcinoma presenting with diplopia as the initial symptom mimicking ocular myasthenia gravis: a case report].[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • MetaanalízisSafety and Efficacy of Efgartigimod for Generalized Myasthenia Gravis: A Systematic Review and Meta-Analysis.Brain and behavior
  • Targeted biologics in muscle strength restoration and corticosteroid sparing for patients post-myasthenic crisis.BMC neurology
  • Association of serum Sema4D and ANGPTL4 levels with disease severity and prognosis in myasthenia gravis patients.Frontiers in neurology
  • Antigen-presenting-cell-associated programs in thymoma-associated myasthenia gravis: public transcriptomic reanalysis and archived cell-model observations.Autoimmunity
  • miR-155 expression associates with pathogenic circulating follicular helper T-cell phenotype in myasthenia gravis.Clinical and experimental immunology
  • Employment status and labour productivity losses associated with myasthenia gravis: an observational study.Archives of public health = Archives belges de sante publique
  • Disease burden among patients with generalized myasthenia gravis in the United States receiving standard of care therapy: the patient perspective.Current medical research and opinion
  • An mRNA-encoded Bispecific T-Cell Engager Targeting Muscle-Specific Tyrosine Kinase for Myasthenia Gravis.Pharmacological research
  • Teaching Video NeuroImage: Posture-Dependent Hypernasal Dysarthria With Velopharyngeal Insufficiency in Myasthenia Gravis.Neurology
  • Integrated Multi-Omics Profiling of Thymoma Identifies Subtype-Specific Remodeling and Myasthenia Gravis-Associated Targets.Journal of proteome research
  • Neutrophil to Lymphocyte Ratio as a Biomarker of Severity in Myasthenia Gravis: A Systematic Review and Meta-Analysis.European neurology
  • PreprintMyasthenia Gravis Activities of Daily Living Deep Phenotyping and Longitudinal.medRxiv : the preprint server for health sciences
  • Antigen-driven CD8+ T cell activation drives the immunopathogenesis of myasthenia gravis-associated myocarditis.Clinical and experimental immunology
  • EsetismertetésPostoperative Neuromuscular Paresis and Overlap Syndrome Related to Immune Checkpoint Inhibitors: A Case Report.JBJS case connector
  • EsetismertetésProbable Seronegative Myasthenia Gravis With Initially Negative Diagnostic Testing: A Case Report.Cureus
  • Immune complex membranoproliferative glomerulonephritis with C3 and IgG-dominant immunohistochemistry staining associated with seronegative myasthenia gravis.BMJ case reports
  • Exacerbations and crises in generalized myasthenia gravis: predictors and associated economic burden in the United States.Frontiers in neurology
  • Reply to the letter: "A correct diagnosis and close, high-quality follow-up care are crucial for successful management of myasthenia gravis patients".Arquivos de neuro-psiquiatria
  • Circulating GFAP and Neurofilament Light Chain in Myasthenia Gravis: A Preliminary Exploratory Case Series.Current neuropharmacology
  • Clinical and bone-turnover outcomes associated with topical herbal plaster adjunctive therapy in older patients with myasthenia gravis and glucocorticoid-associated osteoporotic fragility fracture: a retrospective cohort study with exploratory peripheral-blood BMP-2/Smad/Runx2 analysis.Frontiers in immunology
  • EsetismertetésWhen imaging misleads: Severe bulbar myasthenia gravis with a concomitant tectal lesion: A case report.Surgical neurology international
  • Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient.Frontiers in neurology
  • A correct diagnosis and close, high-quality follow-up care are crucial for successful management of myasthenia gravis patients.Arquivos de neuro-psiquiatria